Bill Sponsor
House Bill 4369
117th Congress(2021-2022)
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
Active
Active
Passed House on Oct 19, 2021
Overview
Text
Introduced
Jul 6, 2021
Latest Action
Oct 20, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4369
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New Jersey
House Votes (1)
Senate Votes (0)
checkPassed on October 19, 2021
Question
On Motion to Suspend the Rules and Pass, as Amended
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
318
House Roll Call Votes
Summary

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021

This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)

Text (4)
October 20, 2021
October 19, 2021
October 19, 2021
Actions (19)
10/20/2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
10/19/2021
The title of the measure was amended. Agreed to without objection.
10/19/2021
Motion to reconsider laid on the table Agreed to without objection.
10/19/2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318). (text: CR H5645-5647)
10/19/2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318).(text: CR H5645-5647)
10/19/2021
Considered as unfinished business. (consideration: CR H5662-5663)
10/19/2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
10/19/2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 4369.
10/19/2021
Considered under suspension of the rules. (consideration: CR H5645-5647)
10/19/2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
10/19/2021
Placed on the Union Calendar, Calendar No. 111.
10/19/2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-151.
07/21/2021
Ordered to be Reported (Amended) by Voice Vote.
07/21/2021
Committee Consideration and Mark-up Session Held.
07/15/2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
07/15/2021
Subcommittee Consideration and Mark-up Session Held.
07/07/2021
Referred to the Subcommittee on Health.
07/06/2021
Referred to the House Committee on Energy and Commerce.
07/06/2021
Introduced in House
Public Record
Record Updated
Mar 8, 2023 8:26:20 PM